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Background: Smoking prevalence in adolescents and young adults is substantially elevated in Tunisia. Moreover,
there is a lack of knowledge regarding the effectiveness and associated factors in smoking cessation interventions
among adolescents and young adults. This study aims at identifying the major factors leading to smoking relapse
among adolescents and young adults in the region of Monastir, Tunisia.
Methods: We carried out a prospective cohort study at the smoking cessation center of the University hospital of
Monastir, Tunisia. The population study consisted of all adolescents and young adults (15–30 years) consulted
during a period of two years (2009 – 2010). A questionnaire was used to explore the patient’s sociodemographic
characteristics, smoking history, nicotine dependence (Fagerstrom test) and anxiety / depression (Hospital Anxiety
and Depression Scale). A telephone survey was conducted in July 2011 to assess smoking cessation results. A
multivariate Cox regression was used to identify predictors of smoking relapses.
Results: A total of 221 adolescents and young adults were included in this study with a mean age of 25.5 ± 3.9
years. At follow up, 59 study participants (26.7%) were abstinent and the overall median abstinence was 2 months.
In the multivariate analysis smoking relapse was associated with being an adolescent patient (HR 2.16; 95% CI:
1.54-3.05), medium or higher nicotine dependence at baseline (HR 2.66, 95% CI: 1.06-7.05 and HR 3.12, 95% CI:
1.20-8.12 respectively), not receiving treatment (HR 1.70, 95% CI: 1.25-2.33) and have friend who is a smoker
(HR 1.63; 95% CI: 0.96-2.79).
Conclusion: The results of this study provide important information about beneficial effect of smoking cessation
support for adolescent and young adults. More efforts must be deployed to deal with contributing factors to
smoking relapse.Introduction
Smoking is one of the leading public health problems
worldwide; it is one of the most preventable causes of
death. In Tunisia, tobacco smoking use is substantially ele-
vated. Adult smoking prevalence is estimated at 17.3%
according to the “BREATHE study” [1]. This rate remains
higher among adolescents rather than adults (from 16 to
29.2%) [2,3]. In addition, cultural factors such as parents
who smoke, doctors, nurses, and teachers who smoke in
the workplace may add to the creation of a pro-smoking
environment [4].
Research suggests that knowledge about the health ef-
fects of smoking is a necessary component of tobacco
control measures and can result in a postponement of* Correspondence: sanaelmhamdi@gmail.com
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distribution, and reproduction in any mediuminitiation and smoking cessation in youth [5]. Smoking
cessation counseling is widely recommended by national
and international health organizations, which underscore
the great potential for a beneficial intervention at the pri-
mary care level. However, smoking cessation outcomes
may be affected by smoker characteristics and life context
variables [6]. Thus the objective of our study was to iden-
tify predictors of smoking relapse among adolescents and
young adults in the region of Monastir, Tunisia.Methods
Design
We conducted a prospective cohort study in the city of
Monastir in Tunisia from 01/01/2009 to 31/12/2010. The
study was carried out in the center of smoking cessation
of Monastir University Hospital. All patients aged 15 to
30 years were included in the study, independently of thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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years or number of previous attempts to quit. All patients
were informed and accepted that their data will be used
for scientific research. We obtained the approval of the
ethical committee of the University Hospital of Monastir
(Tunisia).
Intervention
All smokers received a standardized program for smoking
cessation including behavioral counseling and pharma-
cological treatment. The behavioral counseling consisted
of a 45-minute session dealing with aspects of smoking-
related morbidity and mortality, key issues of nicotine ad-
diction and the development of a specific action plan for
stoppingsmoking. Pharmacotherapy consists of Nicotine
Replacement Therapy (NRT), Varenicline (VAR) and bu-
propion (BUP) and was assigned depending on availability
(supplied by the public health system, free of charge) and
patient comorbidities and smoking dependence. Pharma-
cological therapy was prescribed for at least 12 weeks.
Patients attended follow-up control visits at weeks 2, 4, 8
and 12 after the scheduled quit day and monthly until
the sixth month. Abstinence exceeding sixth months was
assessed by telephone survey.
The following two definitions were used in the study:
Quit date: starting date of smoking abstinence. This
date is chosen by the patient himself
Point date: date of the last assessment of smoking status.
In this study the point date was set on September 15, 2011.
At baseline a detailed smoking history and health data,
was gathered. The questionnaire included items on: Socio-
demographic characters (gender, current age, current acti-
vity, age of cigarette initiation, age of regular smoking and
motivation behind their smoking habit); Daily number of
cigarettes and level of smoking addiction using the French
version of the Fagerström test for nicotine dependence
(FTND) [7] divided into very low dependence (0 – 2), Low /
Medium dependence (3 – 6) and high dependence (7 – 10);
Anxiety and depressive behavior using the French version
of the Hospital Anxiety and Depression Scale (HAD) [8]. A
HAD score ≥ 11 corresponds to anxiety or depressive disor-
ders; Friends that are smokers (the investigators decide to
consider at least one friend who is smokers in the patient
friend’s group; Moderate alcohol consumption (one drink or
less per day for women and two drinks or less per day for
men during the survey [9]); Number of visits to the medical
center and use of pharmacological treatment (corresponding
to the use of NRT,VAR and BUP).
At follow up the patient’s smoking status was deter-
mined by phone calls focus on the following topics: the
current status of smoking, the date of relapse and the
causes associated with it. Moreover, self-reported cigarette
consumption and possible adverse effects were notified at
all follow-up visits.Statistical analysis
In the descriptive analysis, categorical variables are ex-
pressed as proportions and continuous variables as mean
(with standard deviation). Univariate (crude) analysis of
variables from the entire population was performed using
χ2 test and two-sample test for continuous data. Data were
expressed as an odds ratio and 95% confidence interval. All
tests used a significant level of 0.05. In this longitudinal
study participants could make quit attempts at different
times during the follow-up, and thus they also may have
different lengths of follow-up to observe relapse. In this
case we used a multivariate survival analyses (Cox regres-
sion) to identify predictors of relapses. This method allows
for differential follow-up and efficiently accommodates
missing data due to censoring. Models were fitted, inclu-
ding all factors associated with the outcome, in a stepwise
procedure by Kaplan-Meier method. Factors were included
in the model when p ≤ 0.25. To be introduced in the multi-
variate analysis the cutoff point of variables using a visual
analogue scale (motivations of smoking behavior) were de-
fined according to ROC curve.
Data was analyzed by SPSS 17.0.Results
Characteristics of the study sample
Among the attendees of the smoking cessation center, 221
adolescents and young adults were tracked during a period
of 24 months (from January 2009 to December 2010).
The study sample included 210 men (95%) and 11
women (5%). The patient’s mean age was 25.5 years (SD
3.9). The mean age of smoking initiation was 15.2 years
(SD 3.4). A third of our patients (n = 80) consumed alco-
holic drinks occasionally (once a month). The mean num-
ber of daily cigarette use among our patients was 26 (SD
10.4) with a mean FTND about 6.4 (SD 2). Mean scores
for anxiety and depression were 8.4 (SD 4.2) and 5 (SD 3.2)
respectively. Basic information and demographic characte-
ristics of the participants were reported in Table 1.
As depicted in Table 2, several motivations for smoking
behavior were assessed using a visual analog scale from 0
to 10. The main motivation for the use of cigarettes was
to “deal with stress” with a mean of 7.4(SD 3). Other moti-
vations include automatism with a mean of 7.1 (SD 3.2)
and moral support with a mean of 7.3 (SD 3.3).Predictors of smoking relapse
At follow up, 59 patients (26.7%) were abstinent at the
study endpoint with a median abstinence delay of 2 months
(95% CI [1.63 – 2.37]). The median delay to smoking
relapse was 0.75 months (95% CI [0.42 – 1.07]) for adoles-
cents and 2.50 months (95% CI [2.14 – 2.86]) for young
adults (p < 0.01). Table 3 presents the association of each
studied factor with the delay of a quit attempt.
Table 1 Sociodemographic characteristics of the study
sample at baseline (N = 221)
Factors Number (%) Means ± SD







Age of smoking initiation – 15.2 ± 3.4
Age of regular smoking – 18.5 ± 3.4
Current alcohol use –
Yes 80 (36.2)
No 141 (63.8)
Fagerström score – 6.4 ± 2
Daily number of cigarettes
smoked
– 26 ± 10.4
Anxiety score – 8.4 ± 4.2
Depression score – 5 ± 3.2
Have friends that are smokers –
Yes 64 (29)
No 157 (71)
Number of visits to the medical
center for treatment
–
< 3 70 (31.7)
3 visits or more 151 (68.3)
Use of pharmacological treatment –
No 7 (3.2)
Yes 214 (96.8)
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was associated with being an adolescent patient (HR
2.16; 95% C.I: 1.54-3.05), medium or higher nicotine de-
pendence at baseline (HR 2.66, 95% CI: 1.06-7.05 and
HR 3.12, 95% CI: 1.20-8.12 respectively), less than three
visits to the medical center, having not receivedTable 2 Distribution of participants according to the
motivation behind their smoking behavior
Motivation (n) Mean (SD) Minimum Maximum
Automatic gesture (199) 7.1 (3.2) 2 10
Conviviality (192) 4.8 (3.8) 0 10
Enjoyment (189) 5.4 (3.3) 0 10
Dealing with stress (188) 7.4 (3.0) 1 10
Concentration (201) 6.3 (3.4) 0 10
Moral support (186) 7.3 (3.3) 0 10
Fighting obesity (179) 2.2 (0.7) 0 7treatment (HR 1.70, 95% CI: 1.25-2.33) and have friend
who is a smoker (HR 1.63; 95% CI: 0.96-2.79).
Discussion
In this study we used data from the Smoking Cessation
Center of Monastir University Hospital. Among the 310
monitored smokers, 221 answered the phone survey and
the prevalence of abstinence at the endpoint was 26.7%.
This kind of center validated secondary prevention stra-
tegies to help people quit smoking [10]. This rate is
similar to those reported in literature for adolescents
and young adults [11,12]. According to literature, youn-
ger adults were more likely to be successful quitters than
adolescents [13]. In our study we also identified that
adolescence may be related to smoking relapses.
A number of studies have indicated that the likelihood
of smoking cessation is greater in smokers who had
initiated cigarette smoking after the age of 13, in com-
parison to those who had begun earlier [14]. In our
study, the age of smoking initiation as well as the age of
regular smoking was not identified as predictor of smo-
king relapses. The effects of these two ages were perhaps
more important in adulthood rather than adolescence
among Tunisian youth.
Other findings from this study suggest that smoking
cessation might vary also by the level of nicotine depend-
ence. Highly and moderately dependent smokers were
found to be less likely to quit than lower dependent ones.
Indeed research has indicated that higher nicotine de-
pendence in adolescents and young adulthood predicts
later dependence and smoking relapses [15]. Thus, quit-
ting smoking as an adolescent or young adult may
substantially alter the risk for later tobacco dependence.
Research has indicated that decreases in the propor-
tion of friends who smoke were robust predictors of ces-
sation [16]. The likelihood of quitting among young
people is potentially dependent on the extent of smoking
among their peers. Behavioral interventions based on
peer education with social networks can help smoking
cessation efforts [17].
In our study, having a friend who smoked was not a
strongly predictor of smoking relapse. These findings
have also been reported by other African countries. For
example, Egyptian adolescents were noted to be more
influenced by their family’s smoking behavior and
perceived adult smoking norms than their peers’ smo-
king behavior [18].
It is recognized that smoking cessation can be achieved
with or without assistance from healthcare but pharmaco-
therapy may be better in smoking cessation than self-help
[19]. NRT and VAR therapy are noted to be effective stra-
tegies in smoking cessation especially among adults.
Studies proved that they increase the individual’s chance
of successfully quitting smoking [20]. Our study, as recent
Table 3 Unadjusted delay in smoking relapse among





Adolescent 0.75 0.42 – 1.07 < 0.01
Young adult 2.5 2.14 – 2.86
Gender
Female 2.0 1.60 – 2.40 0.52




2.0 1.60 – 2.39 0.70
Unemployed 1.9 0.70 – 3.29
Age at smoking initiation
< 13 years of age 1.2 0.87 – 1.84 0.21
≥ 13 years of age 2.0 1.61 – 2.38
Age at regular smoking
< 18 years of age 1.5 0.88 – 2.11 0.31
≥ 18 years of age 2.5 2.10 – 2.89
Current alcohol use
Yes 2.0 1.07 – 2.92 0.22
No 3.0 1.80 – 4.19
FTND
Very low dependence 18.5 9.30 –
25.20
0.015
Low / Medium dependence 3.0 0.85 – 5.14
High dependence 2.0 1.40 – 2.60
Daily cigarette use
< 20 2.0 1.71 – 3.82 0.081
≥ 20 3.0 1.58 – 2.41
Anxiety
Yes 2.0 1.01 – 2.98 0.26
No 2.5 2.01 – 2.98
Depression
Yes 1.3 0.54 – 2.06 0.22
No 2.0 1.61 – 2.38
Smoking friends
Yes 1.5 0.80-2.19 0.011
No 3.0 2.60-3.40
Number of visits to the medical center
<3 1.0 0.63-1.36 <0.001
3 or more 3.0 1.25-5.66
Use of pharmacological treatment
No 4.0 2.62-9.13 <0.01
Yes 2.0 1.63-2.37
Table 4 Factors associated with relapses delay in
smoking cessation
Factors HR 95% CI p
Fagerström nicotine dependence 0.040
Very low dependence 1 –
Low / Medium dependence 2.66 1.06 – 7.05
High dependence 3.12 1.20 – 8.12
Patient’s age 0.038
Young adult 1 –
Adolescent 2.16 1.54 – 3.05
Number of visits to the medical center < 0.001
< 3 1 –
3 visits or more 0.46 0.33 – 0.64
Smoking friends 0.060
No 1 –
Yes 1.63 0.96 – 2.79
Using treatment < 0.001
Yes 1 –
No 1.70 1.25 – 2.33
Results of a multivariate Cox regression controlling for gender.
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therapies in younger smokers. Other studies in developed
countries showed that the mean number of cigarettes
smoked daily among adolescents and young adults may
not exceed 8 or 9 cigarettes per day [22]. Our data showed
a higher dependent adolescent population with a mean
number of 26 cigarettes smoked daily. With regard to this
result a better availability of professional cessation services
directed to younger smokers and availability of pharmaco-
logical treatment potentially is needed in Tunisia as both
treatment and regular follow-up increase long term smo-
king quitting [23]. A successful treatment may require
close follow up, behavioral support and pharmacological
therapy [24]. Compared to other developing countries
(especially North African countries) current smoking
prevalence of Tunisian adolescents is higher (15.3%) and
initiation susceptibility reaches 25% among boys thus
understanding contributors to smoking initiation and
cessation is important for public health interventions [25].
Limitations and strengths
The important strength of this study is its prospective
character. We performed a prospective cohort study over
a period of two years to identify predictors of smoking
relapse among adolescents and young adults. The advan-
tage of the prospective design is the relative insensitivity
for selection and information bias compared with a case–
control design. Second, the survival “Cox Regression”
allows us to take full account of the censored data. There
are also some limitations to our study. The first is the
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hair and nails analysis) and self-reported smoking cessa-
tion. Second, the small number of women number does
not allow investigation of interaction and separate ana-
lyses for men and women.
Conclusion
The results of this study confirm the beneficial effect of
smoking cessation support for adolescent and young adults.
More efforts must be deployed to deal with contributing
factors to smoking relapse. Furthermore, health education
programmes regarding this potential harm of tobacco use
should be implemented for young people.
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